Sysmex (OTCMKTS:SSMXY – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.415-0.415 for the period, compared to the consensus earnings per share estimate of 0.440. The company issued revenue guidance of $3.5 billion, compared to the consensus revenue estimate of $3.1 billion.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Sysmex has a consensus rating of “Hold”.
Get Our Latest Stock Analysis on Sysmex
Sysmex Stock Up 3.4%
Sysmex stock opened at $13.55 on Tuesday. The company has a market cap of $8.24 billion, a P/E ratio of 32.26 and a beta of 1.20. Sysmex has a 1-year low of $8.01 and a 1-year high of $13.56. The company has a fifty day simple moving average of $12.01 and a 200 day simple moving average of $10.03. The company has a current ratio of 3.40, a quick ratio of 2.53 and a debt-to-equity ratio of 0.23.
Sysmex (OTCMKTS:SSMXY – Get Free Report) last issued its quarterly earnings results on Tuesday, November 10th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.415-0.415 EPS. Research analysts anticipate that Sysmex will post 0.41 earnings per share for the current fiscal year.
Sysmex Company Profile
Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis.
The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.
Read More
- Five stocks we like better than Sysmex
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.
